The Effect of a Community-based Long-acting Antipsychotic-treated Management Model on the Violence Risk of Patients With Schizophrenia: a 1-year, Open-label Randomized Controlled Study
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 24 Apr 2017 Planned number of patients changed from 43 to 150.
- 24 Apr 2017 Study design has been changed from single arm to randomized, parallel group study. Control group has been added to the study, accordingly patient number has also been changed from 43 to 150.
- 24 Apr 2017 Planned End Date changed from 1 Mar 2018 to 1 Apr 2018.